Products derived from 5,8,11-eicosatrienoic acid by the 5-lipoxygenase-leukotriene pathway.

This publication has 13 references indexed in Scilit:

• Stimulation of human leukocyte degranulation by leukotriene B₄ and its ω‐oxidized metabolites
  FEBS Letters, 1981
• Transformation of arachidonic acid in leukocytes. isolation and structural analysis of a novel dihydroxy derivative
  Prostaglandins and Medicine, 1981
• Formation of novel hydroxylated eicosatetraenoic acids in preparations of human polymorphonuclear leukocytes
  FEBS Letters, 1981
• Conversion of 5,8,11-eicosatrienoic acid to leukotrienes C3 and D3.
  Journal of Biological Chemistry, 1981
• LEUKOTRIENE B₄: A MEDIATOR OF VASCULAR PERMEABILITY
  British Journal of Pharmacology, 1981
• Fatty acid structural requirements for leukotriene biosynthesis
  Prostaglandins, 1980
• Leukotriene B, a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytes
  Nature, 1980
• Enzymatic formation of prostaglandin D2 by rat basophilic leukemia cells and normal rat mast cells
  Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1980
• Reduced exudation and increased tissue proliferation during chronic inflammation in rats deprived of endogenous prostaglandin precursors
  Prostaglandins, 1977
• The synthesis of 1‐¹⁴C‐arachidonate and 3‐¹⁴C‐docosa‐7,10,13,16‐tetraenoate
  Lipids, 1971